Rabbit-brain fractions enriched in neuronal cell bodies and in glial cells accumulated norepinephrine, serotonin, dopamine, and -y-aminobutyric acid, substances believed to serve as neurotransmitters in the central nervous system. Both neurons and glia were able to concentrate the monoamine transmitters about 4-fold from a medium containing 0.1-1 uM concentrations. However, the glial-cell fraction concentrated aminobutyrate over a 100-fold from the medium, in contrast to the neuronal fraction, which concentrated this amino acid only 4-fold. The uptake of aminobutyrate by glial cells was 30-50% of that of synaptosome preparations. Its uptake in all fractions was temperature sensitive, sensitive to metabolic inhibitors, and exhibited Km values of 0.72MuM for the neuronal fraction, 0.42MuM for the synaptosomal fraction, and 0.27 uM for the glial-cell fraction. These results are interpreted as evidence that the glial cell is involved in limiting the extracellular build-up of substances that might trigger synaptic transmission by removing any transmitters that may diffuse out of the synaptic cleft during the transmission of impulses. The possible function of the enormous ability of glia and synaptosomes to accumulate aminobutyrate is discussed in light of the actions and distribution of this substance in the central nervous system. Attempts to assess the functional role of glial cells in the central nervous system have centered on ways in which these cells can facilitate neuronal function. From the very early suggestions of Lugaro (1) that glial cells may remove and inactivate the products of neuronal activity, the neuronalglial relationship has proved to be difficult to study. Since neurons and glia are so intimately associated in the structure of the brain, studies on their relationships have been restricted to methodology that enables one to probe single cells. The use of microelectrodes has added to our understanding of the role of the glia in controlling the ionic environment that surrounds neurons (2), while the study of hand-dissected samples containing a small number of glial cells has resulted in some new knowledge of the metabolic relationships between neurons and glia (3, 4).
Attempts to assess the functional role of glial cells in the central nervous system have centered on ways in which these cells can facilitate neuronal function. From the very early suggestions of Lugaro (1) that glial cells may remove and inactivate the products of neuronal activity, the neuronalglial relationship has proved to be difficult to study. Since neurons and glia are so intimately associated in the structure of the brain, studies on their relationships have been restricted to methodology that enables one to probe single cells. The use of microelectrodes has added to our understanding of the role of the glia in controlling the ionic environment that surrounds neurons (2) , while the study of hand-dissected samples containing a small number of glial cells has resulted in some new knowledge of the metabolic relationships between neurons and glia (3, 4) .
More recently centrifugal methods for preparing brain fractions enriched in either intact neurons or glia have allowed direct biochemical studies on these two cell types (5) . For example, the neuronal fraction is (6) (7) (8) much more active in protein synthesis than is the glial fraction; on the other hand, glial cells show a considerably greater ability to ac-cumulate amino acids from the medium (9) . These findings suggest that the glia may supply substrates to neurons, an idea that has also received support from studies in which labeled amino acids were ionophoresed into single glial cells, and were subsequently found in proteins of neuronal cells (10) . In addition, studies on these isolated cell fractions have allowed some definition of the energy-dependent control of the extraneuronal ionic environment by glial cellst.
The present communication deals with the question of glial-cell involvement in the uptake of substances thought to act as synaptic transmitters in the central nervous system. The idea that the glial cell may participate in the inactivation of synaptic transmitters received its initial support from the studies of Koelle in 1955 (11) , in which he showed that although specific acetylcholinesterases (EC 3.1.1.7) were localized in neuronal cells, a nonspecific cholinesterase was widely distributed in glial cells. Although the nonspecific enzyme is, in all likelihood, unimportant in the termination of synaptic transmission, it probably plays a role in eliminating any acetylcholine that escapes from the synaptic cleft. We have studied the uptake of norepinephrine, dopamine, serotonin, and y-aminobutyric acid (NH2 But) by isolated brain fractions enriched in glial and neuronal cells. These substances were chosen since the evidence for their role as chemical transmitters in the mammalian central nervous system is relatively good, if not completely conclusive, and in all cases it has been suggested that synaptic transmission mediated by these substances is terminated by the active uptake of the substance from the synaptic cleft. Moreover, histological studies have shown that glial membrane surrounds the synapse (12 (7, 8) . Cerebral cortexes or whole brains from 6-8 white rabbits were sliced in a mechanical chopper and incubated for 45 min at 370C. The suspended tissue was further disrupted by passage through nylon mesh attached to the end of a plastic syringe. The resulting suspension was filtered through a series of nylon meshes with pore sizes down to 50 ,um; the final filtration included passage through a double layer of 50-MAm nylon mesh. The final filtrate was centrifuged for 5 min at 150 X g, and the resulting pellet was mixed with Ficoll to a final Ficoll concentration of 20%. The neuronal-and glialenriched fractions were prepared by centrifugation on a discontinuous sucrose-Ficoll gradient (13) at 81,500 X g for 120 min in a SW 27 rotor in a Beckman Spinco L2 65 B ultracentrifuge. The fractions were aspirated with pasteur pipettes, diluted with 2-3 volumes of 0.32 M sucrose, and pelleted by centrifugation at 2000 X g.
The synaptosomal fraction was prepared according to Gray and Whittaker (14) . The choppbd rabbit brains were homogenized in 0.32 M sucrose containing 10 mM Tris HCl (pH 7.4), and the homogenate was centrifuged for 10 min at 900 X g. The supernatant fraction was centrifuged for 20 min at 10,000 X g to sediment the crude mitochondrial fraction, which was resuspended in the sucrose solution and placed over layers of 1.2, 1.0, and 0.8 M sucrose in tubes for the SW 25 rotor and centrifuged for 120 min at 55,000 X g.
The band at the interphase between 1.2 and 1.0 M sucrose was collected, diluted with 0.32 M sucrose, and pelleted by centrifugation for 30 min at 10,000 X g.
Measurements of Transmitter Uptake. The neuronal, glial, and synaptosomal pellets were suspended in 0.32 sucrose-10 mM Tris HCl (pH 7.4), at a concentration of 30-40 mg (wet weight) per ml. 0.1-ml aliquots of such suspensions were added to 0.9 ml of incubation medium containing: 35 mM Tris * HCl (pH 7.4); 120 mM NaCl; 5 mM KCl; 2.5 mM MgCl2; 20 mM glucose; 2 mM CaCl2; and radioactive transmitter substances (see Results). Ouabain and 2,4-dinitrophenol were included in the incubation medium in some experiments. In experiments with desmethylimipramine, the tissue fractions were previously incubated in the presence of this substance for 15 min. Incubations were in a shaken water bath at 370C in 15-ml, open test tubes, unless otherwise noted. Immediately after incubation, the tubes were centrifuged for 5 min at 900 X g for the neuronal and glial fractions, and for 5 min at 4000 X g for the synaptosomal fraction. The medium was decanted and the centrifuge tubes were inverted at 0C. The tissue pellets were then collected by pasteur pipettes, the wet weight was determined, and the pellets were placed in 1 ml of Soluene (Packard) in liquid scintillation vials; 15 ml of scintillation fluid [toluene containing Permablend III (Packard) 5.5 g/liter] was added. The samples were then left overnight at room temperature to insure total solubilization of the tissue. Samples of the medium (25 sl) were added to counting vials containing 1 ml of Soluene and 15 ml of toluene-Permablend. The extraparticulate spaces of the pellets were estimated by incubation of the suspensions with radioactive inulin for 15 min before centrifugation; they were calculated as the quotient cpm per mg of pellet/cpm per mg of medium. The radioactivity was measured in a Packard Tricarb liquid scintillation spectrometer at about 50% efficiency for HI and 90% efficiency for 14C.
The capacity of the glial-and neuronal-cell fractions to accumulate neurotransmitter substances was calculated either as cpm per mg of pellet (wet weight)/cpm per mg of medium (at the end of the incubation), or as uptake in umol per mg of pellet (wet weight). Under these assay conditions, the inulin space for all of the particulate pellets was in the range 0.75-0.80.
RESULTS
The results shown in Table 1 indicate that the monoamines norepinephrine, dopamine, and serotonin were concentrated by all three fractions tested, neuronal, glial, and synaptosomal. The synaptosomal fraction accumulated from 3-to 10-fold more monoamine transmitter than either neuronal or glial cells under the conditions used. Values for synaptosomal uptake of dopamine, were not measured, but published data on dopamine uptake by synaptosomes (15) figure) . Application of this correction would, of course, give tissue to medium ratios considerably greater than those appearing in Table 1 , but it was not applied in order to avoid overestimation of the transmitter uptake.
As shown in Table 1 , the inhibitory transmitter NH2But was taken up much more actively by both synaptosomes and glia than were any of the monoamines. The most striking result, however, is that in contrast to the results with the monoamines the glial-cell fraction took up NH2But at a much higher rate than did the neuronal-cell fraction (see Fig. 2 ). first 20 min. The uncorrected tissue to medium ratios attained by glia were in excess of 100, as shown in Fig. 1 . The uptake of NH2But was an energy-dependent process in all three cell fractions; it was inhibited over 90%)N by reduction of the temperature during incubation to 00C ( Table 2 ), suggesting that the uptake is coupled to a temperaturesensitive metabolic pump. In accord with this assumption, the uncoupling agent 2,4-dinitrophenol inhibited uptake of NH2But by glial cells by about 50% (Table 2 ). However, since the cell fractions were not previously depleted of endogenous ATP, the residual uptake of NH2But in the presence of dinitrophenol may reflect the use of such energy reserves. Earlier studies have shown that amino-acid uptake (9) and uptake of monoamine transmitters into synaptosomes (16) require strict coupling to Na+ or K+ movements. To obtain tentative evidence on such coupling, the effect of ouabain on the uptake of NH2But by neuronal, glial, and synaptosomal fractions was examined. 0.1 MM ouabain (Table 2) inhibited NH2But by synaptosomes 91% and by neuronal-and glialcells 79%.
To further characterize the uptake into the three fractions, the rates of initial uptake from concentrations of NH2But from 0.12 AM to 6 ,M were measured. Lineweaver-Burk plots of the data (Fig. 2) show an apparent Km for the neu-0.42 MM, and for the glial fraction of 0.27 MM. Thus, of the three fractions tested, glial cells have the highest affinity for NH2But.
DISCUSSION
These results, in particular the very high accumulation of NH2But by the glial-cell fraction, must be evaluated in terms of the content and purity of the brain fractions used, and in relation to the uptake of these transmitter substances by synaptic endings. The neuronal fraction contains more than 85% neuronal cell bodies, as determined by microscopy (13) , that have been shorn of their axon processes and most of their synaptic endings. The limiting plasma membrane appears to reseal, and the resulting cell bodies are capable of active accumulation of K+ (17) and amino acids (9) . The glial-cell fraction contains 80-90% glia cells and some undefined cell debris (13) . It is critical to determine the degree of contamination of this fraction by synaptic endings to evaluate the present data. Studies in which radioactively-labeled synaptosomes were included in the cell suspension during the preparation of the glial fraction, as well as studies in which isolated glia were studied with the electron microscope, indicate that all the glial fractions examined contained less than 10% synaptic endings.
These estimates of the purity of the cell fractions, together with the striking differences between the relative ability of glia versus neurons to take up NHI2But, lead to the conclusion that NH2But uptake is a real property of the glial cells. The possibility that the NH2But uptake in neurons simply reflects greater damage to the neuronal fraction is contradicted by the data on monoamine accumulation, in which the glia and neuronal fractions exhibit similar monoamine uptake, and by the data that show the same degree of inhibition of the uptake of NH2But by metabolic inhibitors and a reduction in temperature. Since the glial fraction consists of oligodendroglia, astroglia, and microglia, no differentiation as to which type of glial cells are involved in NH2But accumulation is yet possible. Certainly synaptosomal endings appear to be specific with respect to their ability to accumulate transmitters, since NH2But-accumulating synaptosomes have been partially separated from catecholamine-accumulating synaptosomes (18) , as have populations of synaptosomes that contain acetylcholine and 5-hydroxytryptamine (19, 20) . The ability of glia to take up monoamines, although at lower concentrations than those found in synaptic endings, indicates that the glia may function with regard to these transmitters in a similar fashion as they might with regard to acetylcholine. Due to their nonspecific cholinesterase activity, glia have the ability to inactivate any compound that might cause activation of a cholinergic synapse (11) . This mechanism provides a safety valve to limit the possible buildup of cholinergically active substances in the central nervous system. Similarly, the ability of glial cells to accumulate monoamines may be a safety valve to limit their extracellular buildup. Such a role as a safety valve would necessitate active metabolism of these amines upon their entry into the glia. The higher specific activity of monoamine oxidase in glial mitochondria than in neuronal mitochondria (21) is consistent with the view that these cells protect neurons from any deleterious influences of increased extracellular concentrations of monoamines. The stabilization of the external concentration of K+ (11) and the elimination of extra cellular transmitter substances both point to a role for glia as protectors of the environment surrounding neurons.
The uptake of NH2But by glia, neuronal, and synaptosomal fractions presents a somewhat different picture. While the neuronal fraction has a similar, low ability to concentrate monoamines and NH2But, both the glial and synaptosomal fractions have a markedly increased ability to accumulate this amino acid. The glial-cell fraction takes up considerably more glycine (5 times) and glutamic acid (20 times) (two often suggested candidates for central nervous system transmitters) than does the neuronal-cell fraction. These data reflect a general role for glia in the uptake of amino acids (9) . The uptake of NH2But is sensitive to temperature in our hands, in agreement with the data of Iversen and Neal (22) on its uptake by cortical slices. We also found ouabainsensitivity, which indicates that NH2But uptake may be coupled to ionic movements, again in agreement with the data on cortical slices. In addition, the linearity of the Lineweaver-Burk plot (Fig. 2) indicates that the uptake of NH2-But is saturable, and may have differing Km values for each of the fractions examined. The three fractions might have differing affinities, with glial cells exhibiting the greatest affinity for NH2But and the neuronal fraction the least. Iversen and Neal (22) have reported a Km for NH2But uptake by brain-cortical slices of 2.2 X 10-.
['H]NH2But was localized previously by electron-microscopic autoradiography predominantly in synaptic endings in cortical slices (23) . Cortical slices were incubated, washed once, and fixed in gluteraldehyde. Autoradiographs were prepared from 1-to 2-jum sections. The concentration of NH2But in glia is only about 5% that in synaptic terminals, if we assume the degree of damage done to glia during the preparation of the sections was slight. However, the authors report that more than one-third of the labeled NH2But was lost during the fixation procedure. Since the glial cell is a much larger structure than the synaptic terminal, it is reasonable to suppose that the glia suffered more damage during the preparation of samples, so that a greater proportion of the accumulated NH2But was lost by glia than by synaptosomes. Furthermore, other autoradiographic studies (24) electrically unresponsive cells in the pericruciate cortex of the cat were depolarized by NH2But. They suggested that these cells were glia and that the depolarization represented an active transport of NH2But, coupled to the electrogenic sodium pump. Our results support and extend these suggestions that the glial cell is actively concerned with the removal of NH2But from the extracellular space that surrounds neurons.
The enormous potential for the accumulation of NH2But by both the synaptosomal and glial fractions must also be considered in respect to the functional role of this substance in the central nervous system. The magnitude of this uptake may simply reflect the wider distribution of inhibitory synapses mediated by NH2But as compared to the monoamines. Another possibility presents itself, however. In a recent review, Hebb (26) considered the possibility of NH2But as a general "regulator" of neuronal activity, in addition to its role as a specific neuronal transmitter. This concept arises from the suggestion of Wood (27) , who observed an increase in the concentration of extracellular NH2But during hypoxia and felt that this might represent a metabolically-controlled homeostatic device for decreasing the demand on the energy reserves of the brain. This idea is also supported by the observation that the NH2But concentration rises after the administration of aminooxyacetic acid, an inhibitor of NHBut-2-oxoglutarate transaminase, and the increase of NH2But prevents the onset of induced convulsions in experimental animals (28) . In these instances, it appears that NH2But is not released by the activation of inhibitory neuronal pathways, but rather is released in response to general metabolic conditions. This observation, taken together with the high concentrations of NH2But found in the brain (up to 10 miM ref. 29) , tentatively indicate that NH2But may be a generalized regulator of neuronal activity. If 
